Musculoskeletal

RSS

MMP/TNF inhibitors reported by Pfizer

Dec. 12, 1996

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Another British Biotech compound reaches clinical stage

Dec. 9, 1996

FDA tentatively approves generic NSAID

Dec. 6, 1996

SKB, IDEC initiate phase III testing of antirheumatic antibody

Dec. 6, 1996

Connective Therapeutics acquires rheumatoid arthritis Rx from SKB

Dec. 6, 1996

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Dec. 5, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996